Article
Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing.
Journal of clinical microbiology - 1 Jun 2018
Tzou Philip L, Ariyaratne Pramila, Varghese Vici, Lee Charlie, Rakhmanaliev Elian, Villy Carolin, Yee Meiqi, Tan Kevin, Michel Gerd, Pinsky Benjamin A, Shafer Robert W
Abstract excerpt
The ability of next-generation sequencing (NGS) technologies to detect low frequency HIV-1 drug resistance mutations (DRMs) not detected by dideoxynucleotide Sanger sequencing has potential advantages for improved patient outcomes. We compared the performance of an in vitro diagnostic (IVD) NGS assay, the Sentosa SQ HIV genotyping assay for HIV-1 genotypic resistance testing, with Sanger sequencing on 138...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
